NCT04412629 2026-04-06
Cabozantinib in High Grade Neuroendocrine Neoplasms
Washington University School of Medicine
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT03465618 2026-01-07
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT03667092 2025-04-10
GENEBIOLuNET
University Hospital, Toulouse
Phase NA Completed
NCT02348749 2025-03-19
18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed